Free Trial

WealthShield Partners LLC Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Key Points

  • WealthShield Partners LLC increased its stake in UnitedHealth Group by 14.7% during the 1st quarter, bringing its total holdings to 8,932 shares valued at $4.68 million.
  • UnitedHealth Group's quarterly dividend was raised to $2.21 per share, an increase from the previous $2.10, indicating a strong emphasis on returning value to shareholders.
  • The stock price of UnitedHealth Group has shown fluctuations, with a 12-month low of $234.60 and a high of $630.73, reflecting market volatility.
  • Need better tools to track UnitedHealth Group? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

WealthShield Partners LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 8,932 shares of the healthcare conglomerate's stock after acquiring an additional 1,144 shares during the quarter. WealthShield Partners LLC's holdings in UnitedHealth Group were worth $4,678,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Financial Management Professionals Inc. increased its stake in shares of UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock worth $1,165,000 after purchasing an additional 17 shares during the last quarter. Global Wealth Strategies & Associates raised its holdings in shares of UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock worth $47,000 after purchasing an additional 20 shares during the period. Kolinsky Wealth Management LLC raised its holdings in shares of UnitedHealth Group by 1.0% in the 4th quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after purchasing an additional 21 shares during the period. Retirement Planning Group LLC raised its holdings in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock worth $225,000 after purchasing an additional 21 shares during the period. Finally, Net Worth Advisory Group grew its stake in UnitedHealth Group by 0.6% in the 1st quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after buying an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on the stock. Wolfe Research reduced their price objective on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating for the company in a research note on Wednesday, July 16th. JPMorgan Chase & Co. reduced their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday. Finally, TD Securities restated a "hold" rating and set a $308.00 price target (down from $520.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $366.52.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Trading Up 2.5%

UnitedHealth Group stock traded up $6.07 during mid-day trading on Friday, hitting $250.74. The company's stock had a trading volume of 10,146,688 shares, compared to its average volume of 18,404,546. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market cap of $227.46 billion, a price-to-earnings ratio of 10.86, a price-to-earnings-growth ratio of 1.58 and a beta of 0.43. The business has a 50 day moving average price of $291.78 and a 200-day moving average price of $406.82. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period in the prior year, the firm earned $6.80 earnings per share. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 3.5%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's payout ratio is currently 38.30%.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kristen Gil purchased 3,700 shares of the firm's stock in a transaction that occurred on Thursday, May 15th. The stock was bought at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares of the company's stock, valued at $1,035,327.06. This represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines